The leadless intracardiac transcatheter pacing system met safety and efficacy goals, with a safety profile similar to transvenous systems and low stable pacing thresholds.
Does a leadless transcatheter pacemaker provide safe and effective pacing compared to historical performance goals in patients with indications for single-chamber ventricular pacing?
A leadless transcatheter pacemaker demonstrated high implantation success, met prespecified safety and efficacy goals at 6 months, and had fewer major complications compared to a historical transvenous pacemaker cohort.
Tasa de eventos absoluta: 0% vs 0%
In this historical comparison study, the transcatheter pacemaker met the prespecified safety and efficacy goals; it had a safety profile similar to that of a transvenous system while providing low and stable pacing thresholds. (Funded by Medtronic; Micra Transcatheter Pacing Study ClinicalTrials.gov number, NCT02004873.).
Reynolds et al. (Mon,) reported a other. The leadless intracardiac transcatheter pacing system met safety and efficacy goals, with a safety profile similar to transvenous systems and low stable pacing thresholds.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: